SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-May-24 4:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-May-24 | Option Exercise | 273 | $79.02 | $21,572.50 | 4% 7.51K to 7.78K | (3%) |
08-May-24 4:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-May-24 | Planned Private Option Sale | 273 | $140.55 | $38,370.20 | (4%) 7.78K to 7.51K | |
03-Apr-24 4:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Apr-24 | Option Exercise | 272 | $79.02 | $21,493.40 | 4% 7.51K to 7.78K | (3%) |
03-Apr-24 4:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Apr-24 | Planned Private Option Sale | 272 | $137.30 | $37,345.60 | (3%) 7.78K to 7.51K | |
25-Mar-24 6:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Mar-24 | Option Exercise | 5,000 | $103.52 | $517,600.00 | 67% 7.51K to 12.51K | |
25-Mar-24 6:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Mar-24 | Planned Option Sale | 5,000 | $145.06 | $725,320.00 | (40%) 12.51K to 7.51K | |
15-Mar-24 5:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Mar-24 | Option Exercise | 3,000 | $106.02 | $318,060.00 | 40% 7.51K to 10.51K | |
15-Mar-24 5:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Mar-24 | Planned Option Sale | 3,000 | $140.14 | $420,419.00 | (29%) 10.51K to 7.51K | |
12-Mar-24 6:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 11-Mar-24 | Option Exercise | 200 | $106.02 | $21,204.00 | 3% 7.51K to 7.71K | |
12-Mar-24 6:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 11-Mar-24 | Planned Option Sale | 200 | $140.00 | $28,000.00 | (3%) 7.71K to 7.51K | |
12-Mar-24 6:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Mar-24 | Option Exercise | 1,800 | $106.02 | $190,836.00 | 24% 7.51K to 9.31K | |
12-Mar-24 6:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Mar-24 | Planned Option Sale | 1,800 | $140.03 | $252,053.00 | (19%) 9.31K to 7.51K | |
29-Feb-24 7:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 29-Feb-24 | Option Exercise | 273 | $79.02 | $21,572.50 | 4% 7.51K to 7.78K | |
29-Feb-24 7:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 29-Feb-24 | Planned Option Sale | 273 | $135.51 | $36,994.20 | (4%) 7.78K to 7.51K | |
29-Feb-24 7:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Feb-24 | Option Exercise | 6,544 | $79.02 | $517,107.00 | 87% 7.51K to 14.05K | (3%) |
29-Feb-24 7:02 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Feb-24 | Planned Private Option Sale | 6,544 | $135.34 | $885,638.00 | (47%) 14.05K to 7.51K | |
15-Feb-24 5:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 716 | $133.04 | $95,252.80 | (9%) 8.22K to 7.51K | |
02-Feb-24 7:14 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Feb-24 | Sale (Planned) | 623 | $139.77 | $87,076.70 | (8%) 7.49K to 6.87K | |
02-Feb-24 7:14 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 422 | $141.94 | $59,898.70 | (6%) 6.73K to 6.31K | |
30-Aug-23 4:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Aug-23 | Private Sale (Planned) | 1,431 | $107.52 | $153,861.00 | (19%) 7.36K to 5.93K | |
23-Aug-23 8:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 1,404 | $107.42 | $150,820.00 | (23%) 6.05K to 4.64K |